Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | BCHE | P06276 | 1/20 | 0.58 |
| ▸ | ACHE | P22303 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.46 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.44 |
| ▸ | CDK9 | P50750 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2031961 | 0.85 | CA1 (0.56) | CA1CA2BCHEACHETSHR | |
| SCHEMBL915525 | 0.85 | AKR1C3 (0.59) | CA1CA2BCHEACHETSHR | |
| SCHEMBL9499597 | 0.84 | LMNA (0.66) | ALDH1A1MAPK1MAPTLMNASMN1; SMN2 | |
| SCHEMBL2033790 | 0.84 | AKR1C3 (0.50) | CA1CA2BCHEACHETSHR | |
| SCHEMBL4131256 | 0.84 | CA1 (0.55) | CA1CA2BCHEACHETSHR | |
| SCHEMBL2030185 | 0.84 | CA1 (0.55) | CA1CA2BCHEACHETSHR | |
| SCHEMBL1542484 | 0.84 | CA1 (0.55) | CA1CA2BCHEACHETSHR | |
| SCHEMBL3375825 | 0.84 | TSHR (0.50) | TSHRCCNT1CDK9MAPTTP53 | |
| SCHEMBL22340143 | 0.83 | CA1 (0.62) | CA1CA2BCHEACHETSHR | |
| SCHEMBL11225497 | 0.83 | ALDH1A1 (0.51) | CA1CA2BCHEACHETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 394 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540278-B2 | Temperature programmable small molecules for thermoresponsive smart windows and applications thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2026-02-03 | — | — | US | disclosed |
| WO-2025262152-A1 | CONDUCTIVE POLYMER DISPERSIONS FOR IMPROVED STABILITY PERFORMANCE OF CAPACITORS | HERAEUS EPURIO GMBH (DE) | 2025-12-26 | — | — | WO | disclosed |
| EP-4668303-A1 | CONDUCTIVE POLYMER DISPERSIONS FOR IMPROVED STABILITY PERFORMANCE OF CAPACITORS | Heraeus Epurio GmbH (DE) | 2025-12-24 | — | — | EP | disclosed |
| US-20250367188-A1 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS | ARDELYX, INC. (US) | 2025-12-04 | — | — | US | disclosed |
| US-20250353874-A1 | GLUCOCORTICOID RECEPTOR AGONISTS | LILLY CO ELI (US) | 2025-11-20 | — | — | US | disclosed |
| US-20250298333-A1 | POLYESTER RESIN COMPOSITION, ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, DEVELOPER, AND IMAGE FORMING METHOD | Konica Minolta, Inc. (JP) | 2025-09-25 | — | — | US | disclosed |
| US-12404298-B2 | Glucocorticoid receptor agonists | ELI LILLY AND COMPANY (US) | 2025-09-02 | — | — | US | disclosed |
| US-12379315-B2 | Nitrodiarylethenes as fluorescence quenchers for nucleic acid probes | ELITECHGROUP MDX LLC (US) | 2025-08-05 | — | — | US | disclosed |
| EP-4590686-A1 | GLUCOCORTICOID RECEPTOR AGONISTS | Eli Lilly and Company (US) | 2025-07-30 | — | — | EP | disclosed |
| US-20250221998-A1 | DISCOVERY OF COVALENT EGFR INHIBITOR THROUGH CYSTEINE 775 | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2025-07-10 | — | — | US | disclosed |
| US-5194511-A | Optical recording material, films and sheets | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1993-03-16 | — | — | US | disclosed |
| EP-0498184-A2 | Organic nonlinear optical material | MITSUBISHI CHEMICAL CORPORATION (JP) | 1992-08-12 | — | — | EP | disclosed |
| US-5097022-A | Bisazo pigments for use in electrophotographic photoconductors | RICOH COMPANY, LTD. (JP) | 1992-03-17 | — | — | US | disclosed |
| EP-0466094-A2 | Electrophotographic photosensitive member | CANON KABUSHIKI KAISHA (JP) | 1992-01-15 | — | — | EP | disclosed |
| WO-1991003458-A1 | NONLINEAR OPTICAL DEVICE FROM 3-METHYL-4-METHOXY-4'-NITROSTILBENE | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-03-21 | — | — | WO | disclosed |
| US-4985178-A | Nonlinear optical device from 3-methyl-4-methoxy-4'-nitrostilbene | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-01-15 | — | — | US | disclosed |
| US-4966730-A | CAPABILITY OF SECOND HARMONIC GENERATION USING ELECTROOPTICAL MODULAR | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-10-30 | — | — | US | disclosed |
| US-4961631-A | Nonlinear optical devices from derivatives of stilbene | E. I DU PONT DE NEMOURS AND COMPANY (US) | 1990-10-09 | — | — | US | disclosed |
| US-4909964-A | With optical light source and means to direct radiation | E. I. DUPONT DE NEMOURS AND COMPANY (US) | 1990-03-20 | — | — | US | disclosed |
| US-4486519-A | HIGH PHOTOSENSITYIVITY AND FLEXIBILITY | RICOH COMPANY, LTD. (JP) | 1984-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12404298-B2 | Glucocorticoid receptor agonists | NR3C1, NR3C2, MC2R | CA1 3448/4885CA2 1689/4885BCHE 2595/4885 |
| US-20250353874-A1 | GLUCOCORTICOID RECEPTOR AGONISTS | NR3C1, NR3C2, MC2R | CA1 3448/4885CA2 1689/4885BCHE 2595/4885 |
| US-12379315-B2 | Nitrodiarylethenes as fluorescence quenchers for nucleic acid probes | DNTT, NME2, DUT | CA1 3978/4885CA2 3695/4885BCHE 3733/4885 |
| US-12540278-B2 | Temperature programmable small molecules for thermoresponsive smart windows and applications thereof | CRY1, C1S, CRY2 | CA1 331/4885CA2 615/4885BCHE 2868/4885 |
| US-20250367188-A1 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS | SLC10A1, SLC10A2, FABP3 | CA1 2173/4885CA2 584/4885BCHE 3568/4885 |
| US-20250221998-A1 | DISCOVERY OF COVALENT EGFR INHIBITOR THROUGH CYSTEINE 775 | EGFR, ERBB2, ERBB3 | CA1 4470/4885CA2 3932/4885BCHE 4096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.